Patent Yard Sign in
Canadian application, no grantCanada

Use of lipoic acid combination with ascorbic acid in the treatment of cancer

CA 2362288 A1 · Owner: The Center For The Improvement Of Human Functioning International, Inc. · Inventors: Casciari, Joseph; Riordan, Neil H.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Lipoic acid and/or its water soluble salt is used to treat cancer alone or in , combination with ascorbic acid (vitamin C). Alone or in combination it was , shown to be effective on in vitro tumors and mouse tumors. The agents can be administered safely, and have been used effectively in case studies.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 11, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 11, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 11, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 11, 2000
GrantedNo grant recorded
Term endedFebruary 11, 2020
Patent numberCA 2362288 A1
Classification (IPC)A61K31/38 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedFeb 11, 2000Term endedFeb 11, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.